<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To assess the effects of <z:chebi fb="0" ids="15365">acetylsalicylic acid</z:chebi> (<z:chebi fb="37" ids="15365">ASA</z:chebi>) on <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> and interleukin-6 (IL-6) release in the striatum of rats suffering from <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>, we used the microdialysis technique with probes implanted 2 h prior to <z:hpo ids='HP_0001297'>stroke</z:hpo> <z:hpo ids='HP_0003674'>onset</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>A total of 36 rats were randomly assigned to either temporary (90 min, n=18) or permanent (n=18) middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) </plain></SENT>
<SENT sid="2" pm="."><plain>Animals received either a bolus of 40 mg/kg <z:chebi fb="37" ids="15365">ASA</z:chebi> or saline as control 30 min after <z:hpo ids='HP_0001297'>stroke</z:hpo> <z:hpo ids='HP_0003674'>onset</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Permanent MCAO led to large <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes with no differences between treatment with <z:chebi fb="37" ids="15365">ASA</z:chebi> (239.8+/-4.1 mm3) and saline (230.1+/-3.9 mm3, p=0.15) </plain></SENT>
<SENT sid="4" pm="."><plain>In contrast, <z:chebi fb="37" ids="15365">ASA</z:chebi> therapy in temporary <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> (87.2+/-6.2 mm3) reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> size significantly compared to placebo (155.6+/-4.8 mm3, p&lt;0.0001) </plain></SENT>
<SENT sid="5" pm="."><plain>Only in temporary <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, <z:chebi fb="37" ids="15365">ASA</z:chebi> application reduced <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> significantly at the time points 90, 120, and 150 min after MCAO </plain></SENT>
<SENT sid="6" pm="."><plain>Pooled post-ischemic microdialysate concentrations of IL-6 in temporary MCAO were significantly higher after <z:chebi fb="37" ids="15365">ASA</z:chebi> treatment (215+/-81 pg/mL, p=0.0297) than in saline-treated rats (80+/-13 pg/mL) </plain></SENT>
<SENT sid="7" pm="."><plain>In the permanent MCAO group, no difference in IL-6 between the <z:chebi fb="37" ids="15365">ASA</z:chebi> (125+/-21 pg/mL) and saline group (68+/-34 pg/mL) was noted </plain></SENT>
<SENT sid="8" pm="."><plain>No differences were seen for c-fos positive neurons in the penumbra and hippocampus between <z:hpo ids='HP_0000001'>all</z:hpo> groups </plain></SENT>
<SENT sid="9" pm="."><plain>These results suggest that the neuroprotective effect of <z:chebi fb="37" ids="15365">ASA</z:chebi> is reflected by <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> attenuation and IL-6 induction even if given after <z:hpo ids='HP_0001297'>stroke</z:hpo> <z:hpo ids='HP_0003674'>onset</z:hpo>, but only if reperfusion is achieved </plain></SENT>
</text></document>